DTE vs NEUP
DTE (DTE) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported NEUP revenue for 2025-03-31 was $15.0M. Net income was $11.3M. NEUP currently screens at market cap $23.6M.
DTE currently screens at market cap $0. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the DTE and NEUP stock pages for the full models.
Not investment advice.